Primary hypercholesterolemia

There are 2 papers on primary hypercholesterolemia in aging research: 1 trial and 1 observational study in people.

2 papers study it1 more mentions it

2 new papers in 30 daysSee all 3

Human trial1
Humans1

Trial sponsors

Organon
Company3 trialsPhase 41,032 people
Novartis Pharmaceuticals Corporation
Company1 trialPhase 465 people
Merck & Co.
Company7 trialsPhase 38,355 people
Hanlim Pharm
Company2 trialsPhase 3192 people
Kowa Research Europe
Company1 trialPhase 3830 people
Zhejiang Hisun Pharmaceutical
Company1 trialPhase 3720 people
Orient Pharma
Company1 trialPhase 3390 people
Alvogen Korea
Company1 trialPhase 3379 people

Latest

2 papers in 12 months

ESC Congress 2026 AbstractOct 26

Efficacy and safety of SYH2053 in patients with primary hypercholesterolemia or mixed dyslipidemia: a phase II, multicenter, randomized, double-blind, placebo- and active-controlled trial

Randomized trial in 156 peopleInterventions

ESC Congress 2026 AbstractOct 26

Predicted change in 10-year cardiovascular risk one year after initiation of bempedoic acid-based therapy in the MILOS study

Cohort study of 960 peopleBempedoic acid

Lipids in Health and DiseaseSep 22

Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment

Randomized trial in 228 peopleBerberine